Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Characterization and Comparative Outcomes of Younger Multiple Myeloma Patients

Andrea Tufano-Sugarman, Shahidul Islam, Faith E Davies, Gareth Morgan, David Kaminetzky, Oscar B Lahoud, Marc J Braunstein

Blood (2024) 144 (Supplement 1): 5155.

https://doi.org/10.1182/blood-2024-211737

Published: 2024

Journal Articles

Young and Distinct: Clinical Characteristics and Outcomes of Patients 50 or Younger with Multiple Myeloma

Andrea Tufano-Sugarman, Shahidul Islam, Faith E. Davies, Gareth J. Morgan, David Kaminetzky, Marc Braunstein

Blood (2023) 142 (Supplement 1): 6684.

https://doi.org/10.1182/blood-2023-182954

Published: 2023

Journal Articles

Association between Race and Social Deprivation in Patients with Hematologic Malignancies

Emmanuella Kobara, Michael Cottone, Mohammed Shah, Shahidul Islam, Marc Braunstein

Blood (2023) 142 (Supplement 1): 7369.

https://doi.org/10.1182/blood-2023-189170

Published: 2023

Journal Articles

A Randomised Evaluation of Low-Dose Cytarabine Arabinoside Plus Lenalidomide Versus Single-Agent Low-Dose Cytarabine Arabinoside in Older Patients with Acute Myeloid Leukaemia: Results from the LI-1 Trial

Mhairi Copland, Cono Ariti, Ian Thomas, Laura Upton, Mia Sydenham, Priyanka Mehta, Shahidul Islam, Lars Kjeldsen, Alan K. Burnett, Robert Hills, Nigel H. Russell, Mike Dennis

Blood (2021) 138 (Supplement 1): 1266.

https://doi.org/10.1182/blood-2021-147802

Published: 2021

Journal Articles

Outcomes of Patients with Hematologic Malignancies Who Received Inpatient Palliative Care Consultation

Anthony Vito Pasquarella, MD, Angela Ramdhanny, MD, Mina Gendy, DO, Priya Pinto, MD, Shahidul Islam, DrPH, MPH, PStat, Marc Braunstein, MDPhD

Blood (2020) 136 (Supplement 1): 46.

https://doi.org/10.1182/blood-2020-139023

Published: 2020

Journal Articles

Association between Immunoglobulin Isotypes and Cytogenetic Risk Groups in Multiple Myeloma

Ramya Muddasani, DO, Albert Ho, MD PhD, Meredith Akerman, PhD, Shahidul Islam, MPH, PStat, Mitchel Polak, Jamie Andres Suarez-Londono, MD, Marc Braunstein, MD PhD

Blood (2018) 132 (Supplement 1): 5585.

https://doi.org/10.1182/blood-2018-99-118831

Published: 2018

NARROW

Characterization and Comparative Outcomes of Younger Multiple Myeloma Patients

Young and Distinct: Clinical Characteristics and Outcomes of Patients 50 or Younger with Multiple Myeloma

Association between Race and Social Deprivation in Patients with Hematologic Malignancies

A Randomised Evaluation of Low-Dose Cytarabine Arabinoside Plus Lenalidomide Versus Single-Agent Low-Dose Cytarabine Arabinoside in Older Patients with Acute Myeloid Leukaemia: Results from the LI-1 Trial

Outcomes of Patients with Hematologic Malignancies Who Received Inpatient Palliative Care Consultation

Association between Immunoglobulin Isotypes and Cytogenetic Risk Groups in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Characterization and Comparative Outcomes of Younger Multiple Myeloma Patients

Young and Distinct: Clinical Characteristics and Outcomes of Patients 50 or Younger with Multiple Myeloma

Association between Race and Social Deprivation in Patients with Hematologic Malignancies

A Randomised Evaluation of Low-Dose Cytarabine Arabinoside Plus Lenalidomide Versus Single-Agent Low-Dose Cytarabine Arabinoside in Older Patients with Acute Myeloid Leukaemia: Results from the LI-1 Trial

Outcomes of Patients with Hematologic Malignancies Who Received Inpatient Palliative Care Consultation

Association between Immunoglobulin Isotypes and Cytogenetic Risk Groups in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only